pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
371
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
CA-002
Peanut Allergy
Cambridge Allergy Ltd
0
catalysts
Preclinical
CAMKK2 Inhibitors
Transplant Rejection
Eyedesis Biosciences LLC
0
catalysts
Phase 1
CAN-10
Hidradenitis Suppurativa
Otsuka Pharmaceutical Co Ltd
0
catalysts
Preclinical
CD6/CTLA4 CAR-Treg-Dermatological Basket
Psoriasis
← prev
page 4 of 13
next →
131
Pain
89
Neurology
1
Immuthera Inc
0
catalysts
Preclinical
CEL-4000
Rheumatoid Arthritis
CEL-SCI Corp
0
catalysts
Preclinical
CHT-103
Hematological Tumor
Nanjing Miracle Biotechnology Co Ltd
0
catalysts
Preclinical
CHT-104
Hematological Tumor
Nanjing Miracle Biotechnology Co Ltd
0
catalysts
Preclinical
CHT-105
Autoimmune Disorders
Nanjing Miracle Biotechnology Co Ltd
0
catalysts
Phase 1
CLN-978
Systemic Lupus Erythematosus
$CGEM
Cullinan Therapeutics, Inc.
0
catalysts
Phase 2
CNP-106
Myasthenia Gravis
Cour Pharmaceuticals Development Co Inc
0
catalysts
Phase 2
CTO-1681
Cytokine Release Syndrome (Cytokine Storm)
CytoAgents Inc
0
catalysts
Preclinical
CTP-45
Autoimmune Disorders
Celltrion Inc
0
catalysts
Preclinical
CTP-68
Autoimmune Disorders
Celltrion Inc
0
catalysts
Phase 2
CYP-001
Graft Versus Host Disease (GVHD)
Cynata Therapeutics Ltd
0
catalysts
Marketed
Cutaquig
Cutaquig (immune globulin (human))
Primary Immune Deficiency (PID)
$PFE
PFIZER INC
0
catalysts
Marketed
D-Penamine
Depen (penicillamine)
Rheumatoid Arthritis
Mylan Specialty LP
0
catalysts
Phase 2
DBV-135
Milk Allergy
DBV Technologies SA
0
catalysts
Phase 2
DS-7011
Cutaneous Lupus Erythematosus
Daiichi Sankyo Co Ltd
0
catalysts
Phase 2
DSG3-CAART
Pemphigus Vulgaris
$CABA
Cabaletta Bio, Inc.
0
catalysts
Phase 3
Descartes-08
Myasthenia Gravis
$RNAC
Cartesian Therapeutics, Inc.
0
catalysts
Marketed
Desowen
Desonide Actavis (desonide)
Psoriasis
Teva Pharmaceuticals USA Inc
0
catalysts
Phase 2
EG-501
Cognitive Impairment
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Preclinical
EYD-001
Systemic Sclerosis (Scleroderma)
Eydis Bio Inc
0
catalysts
Marketed
Enstilar
Betamethasone Dipropionate + Calcipotriene Perrigo ((betamethasone dipropionate + calcipotriene))
Plaque Psoriasis (Psoriasis Vulgaris)
Perrigo New York Inc
0
catalysts
Phase 2
F-652
Alcoholic Hepatitis
IL22 Receptor
Evive Biotech
0
catalysts
Phase 1
FMT-XBI-302
Graft Versus Host Disease (GVHD)
Shenzhen UnknownBio Biotechnology Co Ltd
0
catalysts
Phase 1
FT-819
Idiopathic Inflammatory Myopathy (IIM)
$FATE
FATE THERAPEUTICS INC
0
catalysts
Preclinical
FT-839
Hematological Tumor
$FATE
FATE THERAPEUTICS INC
0
catalysts
Preclinical
FT-8XX
Unspecified Cancer
$FATE
FATE THERAPEUTICS INC
0
catalysts
Preclinical
Fusion Protein to Antagonize IL1R for Schnitzler Syndrome
Schnitzler Syndrome
R-Pharm
0
catalysts
